nobiletin has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Huang, S; Li, S; Li, X; Liu, M; Ning, L; Tu, C; Yan, Y; Zhang, S | 1 |
| Eissa, LA; El-Mesery, ME; Habeeb, MR; Yousef, EH | 1 |
2 other study(ies) available for nobiletin and Cirrhosis, Liver
| Article | Year |
|---|---|
Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
Topics: Animals; Apoptosis; Cell Line; Diet, High-Fat; Flavones; Hepatic Stellate Cells; Hepatocytes; Lipid Metabolism; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2022 |
Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Doxorubicin; Flavones; Hep G2 Cells; Humans; Liver Cirrhosis; Liver Neoplasms; Polo-Like Kinase 1; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines | 2020 |